I Will Win This
Seven years ago, at age 26, Jasmin Watson-El’s world turned upside down.
She was lying in a hospital in her hometown of Baltimore, Maryland, unable to feel her arms or her legs, and she had just been diagnosed with multiple sclerosis (MS).
“My brain no longer works the same as it did before,” she says. “It takes longer for words to come to me or to digest information, but I am determined to get back to me and
I have strategies to overcome those obstacles.”
She also joined the MS Mindshift, an educational initiative for people living with MS, sponsored by Bristol Myers Squibb (formerly Celgene). She is an MS Ambassador and speaks to groups about living with the daily uncertainties that MS brings. “I hope I’m showing people that even with
MS, they can get up and live. I look at me, and I look at MS and I think, ‘MS will not win. I will win this.’” More information can be found at www.MSMindShift.com.
Bristol Myers Squibb’s ozanimod is currently in Phase 3 clinical trials for relapsing multiple sclerosis.